Relevant bibliographies by topics / Molecular imaging biomarker

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Molecular imaging biomarker'

Author: Grafiati
Published: 2 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Molecular imaging biomarker.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Molecular imaging biomarker"

1

Jeraj, R., and P. Scully. "320 MOLECULAR IMAGING AS A BIOMARKER." Radiotherapy and Oncology 102 (March 2012): S170—S171. http://dx.doi.org/10.1016/s0167-8140(12)70280-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kausar, Rehana, Attia Batool, Ashfaq Ahmad Shah Bukhari, et al. "Crosslinking Salivary Diagnosis with Non-Invasive Insights to Oral Pathology: Novel Systematic Insights to Personalized Medicine in Disease Management." Pakistan Armed Forces Medical Journal 75, no. 3 (2025): 611–16. https://doi.org/10.51253/pafmj.v75i3.13199.

Full text
Abstract:
Objective: To explore the integration of salivary biomarkers, histopathological validation, and advanced imaging for precision diagnosis and management of oral diseases. Methodology: A systematic review was conducted in accordance with the PRISMA 2020 guidelines. Relevant studies from PubMed, Scopus, and Google Scholar were analyzed, with a focus on biomarker discovery, validation, and non-invasive diagnostic modalities in oral pathology. Data extraction emphasized study design, salivary biomarker specificity, imaging correlations, and clinical utility. The risk of bias was assessed using the
APA, Harvard, Vancouver, ISO, and other styles
3

Frost, J. James. "Molecular Imaging to Biomarker Development in Neuroscience." Annals of the New York Academy of Sciences 1144, no. 1 (2008): 251–55. http://dx.doi.org/10.1196/annals.1418.027.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Li, Haonan, Qiyong Gong, and Kui Luo. "Biomarker-driven molecular imaging probes in radiotherapy." Theranostics 14, no. 10 (2024): 4127–46. http://dx.doi.org/10.7150/thno.97768.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Nguyen, Van, and Akiva Mintz. "New frontiers in biomarker-targeted molecular imaging." Cancer Biology & Therapy 8, no. 23 (2009): 2246–49. http://dx.doi.org/10.4161/cbt.8.23.10231.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

van Geel, Jasper J. L., Erik F. J. de Vries, Michel van Kruchten, Geke A. P. Hospers, Andor W. J. M. Glaudemans, and Carolina P. Schröder. "Molecular imaging as biomarker for treatment response and outcome in breast cancer." Therapeutic Advances in Medical Oncology 15 (January 2023): 175883592311707. http://dx.doi.org/10.1177/17588359231170738.

Full text
Abstract:
Molecular imaging, such as positron emission tomography (PET), is increasingly used as biomarker to predict and assess treatment response in breast cancer. The number of biomarkers is expanding with specific tracers for tumour characteristics throughout the body and this information can be used to aid the decision-making process. These measurements include metabolic activity using [18F]fluorodeoxyglucose PET ([18F]FDG-PET), oestrogen receptor (ER) expression using 16α-[18F]Fluoro-17β-oestradiol ([18F]FES)-PET and human epidermal growth factor receptor 2 (HER2) expression using PET with radiola
APA, Harvard, Vancouver, ISO, and other styles
7

McKenna, Amy M., Paul D. Zander, and Lars Wörmer. "Advancing Analytical Frontiers in Molecular Organic Biomarker Research Through Spatial and Mass Resolution." Elements 18, no. 2 (2022): 107–13. http://dx.doi.org/10.2138/gselements.18.2.107.

Full text
Abstract:
Analytical developments have been crucial for the advancement of molecular biomarker research in the Earth sciences. In this chapter, we focus on two areas where recent technological developments have profoundly impacted the use and relevance of molecular organic biomarkers: (1) the increase in spatial resolution heralded by imaging techniques, which results in biomarker-based paleoenvironmental reconstruction with unprecedented temporal resolution; and (2) the accurate, simultaneous characterization of a wide range of compounds in complex matrices enabled by ultra-high-resolution mass spectro
APA, Harvard, Vancouver, ISO, and other styles
8

Uno, Kaname, Tomoyuki Koike, Waku Hatta, Masahiro Saito, Mizuki Tanabe, and Atsushi Masamune. "Development of Advanced Imaging and Molecular Imaging for Barrett’s Neoplasia." Diagnostics 12, no. 10 (2022): 2437. http://dx.doi.org/10.3390/diagnostics12102437.

Full text
Abstract:
Barrett esophagus (BE) is a precursor to a life-threatening esophageal adenocarcinoma (EAC). Surveillance endoscopy with random biopsies is recommended for early intervention against EAC, but its adherence in the clinical setting is poor. Dysplastic lesions with flat architecture and patchy distribution in BE are hardly detected by high-resolution endoscopy, and the surveillance protocol entails issues of time and labor and suboptimal interobserver agreement for diagnosing dysplasia. Therefore, the development of advanced imaging technologies is necessary for Barrett’s surveillance. Recently,
APA, Harvard, Vancouver, ISO, and other styles
9

Palermo, Giovanni, Sara Giannoni, Gabriele Bellini, Gabriele Siciliano, and Roberto Ceravolo. "Dopamine Transporter Imaging, Current Status of a Potential Biomarker: A Comprehensive Review." International Journal of Molecular Sciences 22, no. 20 (2021): 11234. http://dx.doi.org/10.3390/ijms222011234.

Full text
Abstract:
A major goal of current clinical research in Parkinson’s disease (PD) is the validation and standardization of biomarkers enabling early diagnosis, predicting outcomes, understanding PD pathophysiology, and demonstrating target engagement in clinical trials. Molecular imaging with specific dopamine-related tracers offers a practical indirect imaging biomarker of PD, serving as a powerful tool to assess the status of presynaptic nigrostriatal terminals. In this review we provide an update on the dopamine transporter (DAT) imaging in PD and translate recent findings to potentially valuable clini
APA, Harvard, Vancouver, ISO, and other styles
10

Root, Alex. "Mathematical Modeling of The Challenge to Detect Pancreatic Adenocarcinoma Early with Biomarkers." Challenges 10, no. 1 (2019): 26. http://dx.doi.org/10.3390/challe10010026.

Full text
Abstract:
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive tumor type and is usually detected at late stage. Here, mathematical modeling is used to assess the feasibility of two-step early detection with biomarkers, followed by confirmatory imaging. A one-compartment model of biomarker concentration in blood was parameterized and analyzed. Tumor growth models were generated from two competing genomic evolution models: gradual tumor evolution and punctuated equilibrium. When a biomarker is produced by the tumor at moderate-to-high secretion rates, both evolutionary models indicate that early dete
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Molecular imaging biomarker"

1

Vargas, Sanchez Jeinny. "In vivo peptide biomarker screening for molecular imaging in eae neuroinflammation." Thesis, Bordeaux 2, 2013. http://www.theses.fr/2013BOR22102/document.

Full text
Abstract:
Dans les maladies neurodégénératives comme la sclérose en plaques, la neuro-inflammation modifie l'activité de la barrière hémato-encéphalique (BHE) par des altérations cellulaires et moléculaires complexes. La caractérisation de tels changements moléculaires par une approche d'étiquetage in vivo justifie la recherche d’outils de ciblage fiables et de biomarqueurs. Les stratégies pour définir in vivo ces marqueurs sont cependant compliquées par la pléthore de molécules cibles accessibles, par l’intrication des régions atteintes au sein du tissu sain et par les altérations structurales potentie
APA, Harvard, Vancouver, ISO, and other styles
2

Liu, Guanshu. "DEVELOPMENT OF PARACEST MRI TO DETECT CANCER BIOMARKERS." Case Western Reserve University School of Graduate Studies / OhioLINK, 2008. http://rave.ohiolink.edu/etdc/view?acc_num=case1199932704.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bain, Gillian H. "Combining molecular and imaging biomarkers to optimise response prediction in oesphagogastric adenocarcinoma." Thesis, University of Aberdeen, 2013. http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=195749.

Full text
Abstract:
Predicting whether patients will respond to particular treatments and identifying molecular targets for novel innovative therapies within the context of a paradigm shift towards individualised selection of therapy is a priority for translational research in oesophagogastric adenocarcinoma. Changes in tumour glucose metabolism detected early in the course of chemotherapy (14 days) by fluorodeoxyglucose-positron emission tomography (FDG-PET), has demonstrated efficacy for prediction of response and clinical benefit from chemotherapy. However, while the specificity of FDG-PET is high (95%), sensi
APA, Harvard, Vancouver, ISO, and other styles
4

Suh, Yae-Eun. "Molecular and imaging biomarkers of radioresistance in head and neck squamous cell carcinoma." Thesis, King's College London (University of London), 2016. https://kclpure.kcl.ac.uk/portal/en/theses/molecular-and-imaging-biomarkers-of-radioresistance-in-head-and-neck-squamous-cell-carcinoma(da659ce4-c8cf-4a7f-a07f-cf0775946c26).html.

Full text
Abstract:
The development of individualised treatments in head and neck squamous cell carcinoma (HNSCC) requires understanding of the molecular biology of cancer and the ability to translate this into therapy. Due to the heterogeneity of HNSCCs biomarkers are needed to identify the mechanisms of tumourigenesis and treatment resistance to improve outcome. Radioresistance is a major cause of treatment failure and early identification is key to the development of treatment strategies to overcome resistance and improve disease control. MicroRNAs are small endogenous non-coding RNAs that regulate gene expres
APA, Harvard, Vancouver, ISO, and other styles
5

Rebaud, Louis. "Whole-body / total-body biomarkers in PET imaging." Electronic Thesis or Diss., université Paris-Saclay, 2024. http://www.theses.fr/2024UPAST047.

Full text
Abstract:
Cette thèse, réalisée en partenariat avec l'Institut Curie et Siemens Healthineers, explore l'utilisation de l'imagerie par tomographie par émission de positrons (TEP) pour le pronostic du cancer, en se concentrant sur les lymphomes non hodgkiniens, en particulier le lymphome folliculaire (FL) et le lymphome diffus à grandes cellules B (DLBCL). Partant de l'hypothèse que les biomarqueurs actuels calculés dans les images TEP sous-utilisent leur richesse en informations, ce travail se concentre sur la recherche de nouveaux biomarqueurs en imagerie TEP corps entier. Une première approche manuelle
APA, Harvard, Vancouver, ISO, and other styles
6

Rybaczyk, Leszek A. "Comparative Gene Expression Analysis To Identify Common Factors In Multiple Cancers." The Ohio State University, 2008. http://rave.ohiolink.edu/etdc/view?acc_num=osu1211958921.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Spiegelberg, Diana. "Towards Personalized Cancer Therapy : New Diagnostic Biomarkers and Radiosensitization Strategies." Doctoral thesis, Uppsala universitet, Medicinsk strålningsvetenskap, 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-247539.

Full text
Abstract:
This thesis focuses on the evaluation of biomarkers for radio-immunodiagnostics and radio-immunotherapy and on radiosensitization strategies after HSP90 inhibition, as a step towards more personalized cancer medicine. There is a need to develop new tracers that target cancer-specific biomarkers to improve diagnostic imaging, as well as to combine treatment strategies to potentiate synergistic effects. Special focus has been on the cell surface molecule CD44 and its oncogenic variants, which were found to exhibit unique expression patterns in head and neck squamous cell carcinoma (HNSCC). The v
APA, Harvard, Vancouver, ISO, and other styles
8

Seppi, Dario. "Integration of advanced molecular analyses and magnetic resonance imaging for the identification of biomarkers of disease progression in multiple sclerosis." Doctoral thesis, Università degli studi di Padova, 2016. http://hdl.handle.net/11577/3427119.

Full text
Abstract:
Background. In the last 15 years, it has become increasingly accepted that cerebral grey matter (GM) damage in MS is evident since early MS stages and provides the best correlate of the rate of clinical progression since early disease stages. The lack of substantial inflammatory infiltrates, complement deposition and blood brain barrier damage in MS cortical lesions led to the initial suggestion that the mechanisms underlying GM and white matter (WM) pathology substantially differ and that activated microglia are the dominant effector cell population causing GM damage. Furthermore, in the last
APA, Harvard, Vancouver, ISO, and other styles
9

Wirtz, Martina Verfasser], Hans-Jürgen [Akademischer Betreuer] [Wester, Sibylle [Gutachter] Ziegler, and Klemens M. [Gutachter] Scheidhauer. "Development of biomarkers for molecular imaging and endoradiotherapy of prostate cancer / Martina Wirtz ; Gutachter: Sibylle Ziegler, Klemens M. Scheidhauer ; Betreuer: Hans-Jürgen Wester." München : Universitätsbibliothek der TU München, 2015. http://d-nb.info/1113749091/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Wirtz, Martina [Verfasser], Hans-Jürgen [Akademischer Betreuer] Wester, Sibylle [Gutachter] Ziegler, and Klemens M. [Gutachter] Scheidhauer. "Development of biomarkers for molecular imaging and endoradiotherapy of prostate cancer / Martina Wirtz ; Gutachter: Sibylle Ziegler, Klemens M. Scheidhauer ; Betreuer: Hans-Jürgen Wester." München : Universitätsbibliothek der TU München, 2015. http://d-nb.info/1113749091/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Molecular imaging biomarker"

1

Bjurlin, Marc A., and Richard S. Matulewicz. Comprehensive Diagnostic Approach to Bladder Cancer: Molecular Imaging and Biomarkers. Springer International Publishing AG, 2022.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bjurlin, Marc A., and Richard S. Matulewicz. Comprehensive Diagnostic Approach to Bladder Cancer: Molecular Imaging and Biomarkers. Springer International Publishing AG, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Cassidy, Jim, Donald Bissett, Roy A. J. Spence OBE, Roy A. J. Spence OBE, Miranda Payne, and Gareth Morris-Stiff. Biomarkers and cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199689842.003.0040.

Full text
Abstract:
Biomarkers and cancer defines these markers and outlines their role in diagnosis, prognosis, prediction of response, and response assessment of a variety of cancers. Established biomarkers are reviewed, and the potential for development of new biomarkers offered by the dramatic progress in both the understanding of molecular biology and the development of laboratory techniques is emphasised. The field of signal transduction has already proved fruitful, with identification of markers allowing successful targeted therapy in a range of cancers. Progress is anticipated also in tumour imaging, with
APA, Harvard, Vancouver, ISO, and other styles
4

Luo, Yongwen, Yi Zhang, Yu Xiao, and Fang-Ming Deng, eds. Molecular Biomarkers and Imaging Markers in the Prediction, Diagnosis, and Prognosis of Bladder Cancer. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88976-629-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Limaye, Ajit P., and Lynne Strasfeld. Introduction. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199938568.003.0200.

Full text
Abstract:
Chapter 2 focuses on the solid organ transplantation (SOT). The Solid organ transplantation (SOT) is undertaken to restore organ function for patients with failing or end-stage disease of the liver, heart, lung, kidneys, and/or pancreas or to re-establish function in patients with short gut or other disorders of the intestinal tract. Organ transplantation requires lifelong maintenance immune suppression to prevent organ rejection. Infection can be related to donor transmission, reactivation from latency in the recipient, or acquisition de novo post-transplant. The evaluation of suspected infec
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Molecular imaging biomarker"

1

Kim, Hahnsung, Yin Wu, Daisy Villano, Dario Livio Longo, Michael T. McMahon, and Phillip Zhe Sun. "Analysis Protocol for the Quantification of Renal pH Using Chemical Exchange Saturation Transfer (CEST) MRI." In Methods in Molecular Biology. Springer US, 2021. http://dx.doi.org/10.1007/978-1-0716-0978-1_40.

Full text
Abstract:
AbstractThe kidney plays a major role in maintaining body pH homeostasis. Renal pH, in particular, changes immediately following injuries such as intoxication and ischemia, making pH an early biomarker for kidney injury before the symptom onset and complementary to well-established laboratory tests. Because of this, it is imperative to develop minimally invasive renal pH imaging exams and test pH as a new diagnostic biomarker in animal models of kidney injury before clinical translation. Briefly, iodinated contrast agents approved by the US Food and Drug Administration (FDA) for computed tomog
APA, Harvard, Vancouver, ISO, and other styles
2

Hectors, Stefanie J., Philippe Garteiser, Sabrina Doblas, et al. "MRI Mapping of Renal T1: Basic Concept." In Methods in Molecular Biology. Springer US, 2021. http://dx.doi.org/10.1007/978-1-0716-0978-1_9.

Full text
Abstract:
AbstractIn renal MRI, measurement of the T1 relaxation time of water molecules may provide a valuable biomarker for a variety of pathological conditions. Due to its sensitivity to the tissue microenvironment, T1 has gained substantial interest for noninvasive imaging of renal pathology, including inflammation and fibrosis. In this chapter, we will discuss the basic concept of T1 mapping and different T1 measurement techniques and we will provide an overview of emerging preclinical applications of T1 for imaging of kidney disease.This chapter is based upon work from the COST Action PARENCHIMA,
APA, Harvard, Vancouver, ISO, and other styles
3

Albano, Domenico, Francesco Dondi, Pietro Bellini, and Francesco Bertagna. "Biomarkers and Molecular Imaging in Postoperative DTC Management." In Integrated Diagnostics and Theranostics of Thyroid Diseases. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-35213-3_8.

Full text
Abstract:
AbstractThe standard of care for differentiated thyroid carcinoma (DTC) includes surgery, risk-adapted postoperative radioiodine [iodine-131 (131I)] therapy, individualized thyroid hormone therapy, and follow-up for detection of patients with recurrent or persistent disease.Recently, several international associations like ATA, EANM, and SNMMI developed specific guidelines for the management of these patients. They shared that an individualized risk-adapted approach should be suggested considering the main clinical, epidemiological, and histopathological features. The postoperative management
APA, Harvard, Vancouver, ISO, and other styles
4

Deininger, Sören-Oliver, Michael Becker, and Detlev Suckau. "Tutorial: Multivariate Statistical Treatment of Imaging Data for Clinical Biomarker Discovery." In Methods in Molecular Biology. Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60761-746-4_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Quanico, Jusal, Julien Franck, Maxence Wisztorski, Michel Salzet, and Isabelle Fournier. "Progress and Potential of Imaging Mass Spectrometry Applied to Biomarker Discovery." In Methods in Molecular Biology. Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-6952-4_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Gaonkar, Bilwaj, Kirstin Cook, Bryan Yoo, Banafsheh Salehi, and Luke Macyszyn. "Imaging Biomarker Development for Lower Back Pain Using Machine Learning: How Image Analysis Can Help Back Pain." In Methods in Molecular Biology. Springer US, 2021. http://dx.doi.org/10.1007/978-1-0716-1803-5_33.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Chen, Hui, Sylvère Durand, Olivia Bawa, et al. "Biomarker Identification in Liver Cancers Using Desorption Electrospray Ionization Mass Spectrometry (DESI-MS) Imaging: An Approach for Spatially Resolved Metabolomics." In Methods in Molecular Biology. Springer US, 2024. http://dx.doi.org/10.1007/978-1-0716-3694-7_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Shaikh, Sikandar. "Molecular Imaging Biomarkers and Agents." In Advances in Imaging. Springer Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-9535-3_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Paech, Daniel, and Heinz-Peter Schlemmer. "Clinical MR Biomarkers." In Molecular Imaging in Oncology. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-42618-7_21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Alberich-Bayarri, Angel, Ana Jiménez-Pastor, and Irene Mayorga-Ruiz. "Imaging Biomarkers and Their Meaning for Molecular Imaging." In Artificial Intelligence/Machine Learning in Nuclear Medicine and Hybrid Imaging. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-00119-2_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Molecular imaging biomarker"

1

Maryam, Siddra, Amine Benazza, Edward Fahy, et al. "Detection of oral potentially malignant disorders using liquid saliva in a novel optofluidic photonic crystal fiber." In Optical Molecular Probes, Imaging and Drug Delivery. Optica Publishing Group, 2025. https://doi.org/10.1364/omp.2025.om3e.4.

Full text
Abstract:
In this work we demonstrate novel optofluidic photonic crystal fiber to study biomarker changes associated with oral potentially malignant diseases from liquid saliva. The results show good agreement with in vivo tissue Raman measurements.
APA, Harvard, Vancouver, ISO, and other styles
2

Mickert, Matthias, Magnus Helgstrand, Sanathana Konugolu Venkata Sekar, et al. "Increasing Objectivity in Quantitative Analysis in Immune-Histochemistry Biomarker Mapping using Upconverting Nanoparticles." In Optical Molecular Probes, Imaging and Drug Delivery. Optica Publishing Group, 2025. https://doi.org/10.1364/omp.2025.otu1e.2.

Full text
Abstract:
Today immunohistochemistry (IHC) stains molecular biomarkers for treatment stratification. IHC can become increasingly objective by improving sensitivity, quantification and multiplexing capabilities. We use upconverting nanoparticles to achieve this, potentially leading to improved treatment outcomes.
APA, Harvard, Vancouver, ISO, and other styles
3

Danis, Laurence, Valensia N. Anthony, Sandryne David, et al. "Development of a high-throughput wide-field imaging robotic system for assessing margin status based on cancer biomarkers derived from Raman spectroscopy with preliminary validation in lumpectomy specimens from breast-conserving surgery." In Molecular-Guided Surgery: Molecules, Devices, and Applications XI, edited by Summer L. Gibbs and Kenneth M. Tichauer. SPIE, 2025. https://doi.org/10.1117/12.3041415.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Schmidt, Katharina, Naoto Asai, Andres de los Santos Pereira, et al. "Real-time monitoring of single molecules with rolling circle amplification by surface plasmon-enhanced fluorescence imaging." In Optical Sensors. Optica Publishing Group, 2024. https://doi.org/10.1364/sensors.2024.sw1c.5.

Full text
Abstract:
The immuno-rolling circle amplification assay is demonstrated for the detection of cancer biomarkers in serum samples with high sensitivity. Real-time imaging of single molecules is possible with surface plasmon-enhanced fluorescence.
APA, Harvard, Vancouver, ISO, and other styles
5

Collins, Hannah, Rahul Pal, Murali Krishnamoorthy, et al. "Fluorescence Lifetime (FLT)-Enhanced Tumor Imaging with Biomarker-Targeted Agents." In Clinical and Translational Biophotonics. Optica Publishing Group, 2024. http://dx.doi.org/10.1364/translational.2024.ts5b.2.

Full text
Abstract:
Fluorescence lifetime (FLT) imaging of biomarker-targeted probes enhances tumor identification accuracy compared to fluorescence intensity. We demonstrate using microscopy that FLT of diverse probes, acting via molecular expression or physiological biomarkers, enables cellular-resolution tumor identification.
APA, Harvard, Vancouver, ISO, and other styles
6

McClatchy, David M., Elizabeth J. Rizzo, Stephen C. Kanick, et al. "Sub-diffusive spatial frequency domain imaging: light scattering as a biomarker (Conference Presentation)." In Molecular-Guided Surgery: Molecules, Devices, and Applications III, edited by Brian W. Pogue and Sylvain Gioux. SPIE, 2017. http://dx.doi.org/10.1117/12.2252589.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Tu, Haohua. "Supercontinuum Intrinsic Fluorescence Imaging (SCIFI) Empowers Biomarker Discovery." In Microscopy Histopathology and Analytics. Optica Publishing Group, 2024. http://dx.doi.org/10.1364/microscopy.2024.mm5a.3.

Full text
Abstract:
In contrast to other forms of fluorescence microscopy, SCIFI maximizes the information content beyond fluorescence intensity while minimizing the harm to fragile living systems, resulting in abundant label-free cellular/molecular biomarkers in biology and medicine.
APA, Harvard, Vancouver, ISO, and other styles
8

Liang, Feng, and zhongcong xie. "Nanobeam and Nanoneedle technology study new biomarker and single molecular interaction." In Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications XIX, edited by Dror Fixler, Sebastian Wachsmann-Hogiu, and Ewa M. Goldys. SPIE, 2022. http://dx.doi.org/10.1117/12.2607664.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Afsharan, Hadi, Michael J. Hackmann, Qiang Wang, Chulmin Joo, Dilusha Silva, and Barry Cense. "Assessment of Retinal Blood Vessel Wall Integrity with Polarization-Sensitive Optical Coherence Tomography as a Disease Biomarker." In Optical Molecular Probes, Imaging and Drug Delivery. OSA, 2021. http://dx.doi.org/10.1364/omp.2021.of1e.1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Liu, Cheng-Hui, Yan Zhou, Binlin Wu, et al. "Visible resonance Raman spectroscopy detect key molecular biomarker vibrations to characterize for human brain gliomas." In Biomedical Imaging and Sensing Conference, edited by Osamu Matoba, Yasuhiro Awatsuji, Toyohiko Yatagai, and Yoshihisa Aizu. SPIE, 2018. http://dx.doi.org/10.1117/12.2318751.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Molecular imaging biomarker"

1

Pagel, Mark. Novel Molecular Imaging Agents to Detect Biomarkers of Metastatic Breast Cancer. Defense Technical Information Center, 2006. http://dx.doi.org/10.21236/ada458457.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Peehl, Donna M. Discovery of Hyperpolarized Molecular Imaging Biomarkers in a Novel Prostate Tissue Slice Culture Model. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada580953.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kurhanewicz, John. Discovery of Hyperpolarized Molecular Imaging Biomarkers in a Novel Prostate Tissue Slice Culture Model. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada584506.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ronen, Sabrina. Discovery of Hyperpolarized Molecular Imaging Biomarkers in a Novel Prostate Tissue Slice Culture Model. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada585099.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ronen, Sabrina. Discovery of Hyperpolarized Molecular Imaging Biomarkers in a Novel Prostate Tissue Slice Culture Model. Defense Technical Information Center, 2011. http://dx.doi.org/10.21236/ada549047.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Peehl, Donna. Discovery of Hyperpolarized Molecular Imaging Biomarkers in a Novel Prostate Tissue Slice Culture Model. Defense Technical Information Center, 2011. http://dx.doi.org/10.21236/ada549130.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kurhanewicz, John. Discovery of Hyperpolarized Molecular Imaging Biomarkers in a Novel Prostate Tissue Slice Culture Model. Defense Technical Information Center, 2011. http://dx.doi.org/10.21236/ada549212.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Molecular imaging biomarker' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography